WEDNESDAY, Aug. 29, 2018 -- For patients with hemophilia A without factor VIII inhibitors, emicizumab prophylaxis leads to a significantly reduced bleeding rate, according to a study published in the Aug. 30 issue of the New England Journal of...
Original Article: Emicizumab Prophylaxis Cuts Bleeding in Hemophilia A